ClinicalTrials.govpublic full text
Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients
cardiac arrest, neu2000kwl, cerebral performance category, out-of-hospital cardiac arrest, neuroprotection, glutamate, n-methyl-d-aspartate (nmda) receptor antagonist, anti-oxidant, free radical, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 853408
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.